Skip to main content
. 2017 Nov 17;93(2):222–231. doi: 10.1002/ajh.24959

Figure 2.

Figure 2

Treatment Duration and Overall Survival. A. Six subjects (46%) received treatment for almost 2 years (95–99 weeks). Ten subjects (77%) were alive at end of study. Nine subjects (69%) survived >50 weeks and 4 (31%) survived >2 years. B. There was no significant difference in OS between the 2 treatment groups